# Anti–G Protein–Coupled Receptor, Class C Group 5 Member D Chimeric Antigen Receptor T Cells in Patients With Relapsed or Refractory Multiple Myeloma: A Single-Arm, Phase Ⅱ Trial

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/anti-g-protein-coupled-receptor-class-c-group-5-member-d-chimeric-antigen/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Jieyun Xia,Hujun Li,Zhiling Yan,Dian Zhou,Ying Wang,Yuekun Qi,Jiang Cao,Depeng Li,Hai Cheng,Wei Sang,Feng Zhu,Haiying Sun,Wei Chen,Kunming Qi,Dongmei Yan,Tingting Qiu,Jianlin Qiao,Ruosi Yao,Yang Liu,Xue Wang,Yanlei Zhang,Shuixiu Peng,Chih-Hua Huang,Junnian Zheng,Zhenyu Li,Alex H. Chang,Kailin Xu |
| Citations | 90 |
| DOI | 10.1200/jco.22.01824 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://ascopubs.org/doi/pdf/10.1200/JCO.22.01824?role=tab |
| OpenAlex ID | https://openalex.org/W4323351721 |
| PMID | 36881785 |
| Type | article |
| Year | 2023 |

## Paper authors

- [Jieyun Xia](https://scholariq.org/researchers/jieyun-xia/)

## Paper journal

- [Journal of Clinical Oncology](https://scholariq.org/journals/journal-of-clinical-oncology/)

## Paper primary topic

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)

## Paper topics

- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [Multiple Myeloma Research and Treatments](https://scholariq.org/topics/multiple-myeloma-research-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.